AstraZeneca's Enhertu gets fresh EU approval, Science Group ups Ricardo stake further
Stocks to watch AstraZeneca and Daiichi Sankyo's Enhertu has been approved in the European Union as a monotherapy for the treatment of adult patients with unresectable or metastatic hormone receptor (HR)-positive, HER2-low or HER2-ultralow breast …